Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment

The rate of cognitive decline among patients with amnestic mild cognitive impairment (aMCI) varies, and it is thus crucial to accurately predict the probability of cognitive deterioration in patients with MCI. We compared the potential of cytokines with amyloid beta (Aβ) and tau biomarkers for predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chih-Sung, Tsai, Chia-Lin, Lin, Guan-Yu, Lee, Jiunn-Tay, Lin, Yu-Kai, Chu, Che-Sheng, Sung, Yueh-Feng, Tsai, Chia-Kuang, Yeh, Ta-Chuan, Chu, Hsuan-Te, Su, Ming-Wei, Yang, Fu-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193360/
https://www.ncbi.nlm.nih.gov/pubmed/34122046
http://dx.doi.org/10.3389/fnagi.2021.670115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193360/
https://www.ncbi.nlm.nih.gov/pubmed/34122046
http://dx.doi.org/10.3389/fnagi.2021.670115

Ejemplares similares